Navigation Links
Stem Cell Answer to Infertility in Five Years, Says Scientist

Research on stem cells as a cure for infertility has made considerable progress. In five years it should be possible to grow mature sperm from adult stem cells, says Dr.Karim Nayerina, noted Iranian-born biomedical scientist.

In July 2006, Dr. Nayernia, a professor of stem biology at the University of Newcastle upon Tyne reported that he and his team had successfully coaxed the embryonic stem cells of mice into becoming mature sperm. This sperm was successfully used to fertilize eggs, resulting in the live birth of seven mice. While six of the seven mice survived to adulthood, each mouse exhibited some variety of abnormal development, such as stunted growth and difficulty walking.

More recently, Dr. Nayernia has focused his research on the development of sperm cells from adult stem cells found in the bone marrow tissue of rats, rather than from embryonic stem cells. Dr. Nayernia and his team were able to cause the adult stem cells to undergo the first two of the three divisions required for these cells to become sperm cells.

While his teams inability to turn adult rat stem cells into fully mature sperm has solicited criticism and caution from the scientific community, Dr. Nayernia has proceeded to experiment with samples of stem cells taken from the bone marrow of human males.

The scientists added both vitamin A and proteins (both of which purportedly encourage the development of sperm) to the adult stem cells. The procedure showed promise as the human stem cells began to develop into sperm; however, these developing stem cells never reached full maturity.

While success with human adult stem cells has remained elusive, Dr. Nayernia remains optimistic about the culmination of his research with stem cells, embryonic and adult, mouse and human. He believes that the ability to use human adult stem cells to grow mature sperm and implant them into the infertile males testes is no more than five years
'"/>




Page: 1 2

Related medicine news :

1. Answer on SARS 3 to 4 weeks away
2. Answers For OCD soon
3. The Answer To Prevent Osteoporosis
4. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
5. An Answer To Obesity: Weight Control Protein
6. Chronic Myelogenous Leukemia (CML) Has An Answer Now!
7. Synthetic Bone Tissue Could Be the Answer to Disfigurement Caused by Oral Cancer
8. Emotional Engagement of Husband - A Final Answer To What Women Want
9. US Preparing To Answer Japans Queries On Beef Exports
10. Running Alone Might Not Be The Answer
11. Cancer Vaccine Could Serve As an Answer to Prevent Most of the Cancer
Post Your Comments:
(Date:5/22/2008)...Milk Mustache Campaign and Everyday Food Team ... WASHINGTON, May 22 /PRNewswire/ -- America, star...k Mustache Campaign and Everyday Food magazine,are...onor of June Dairy,Month., Whether it,s a sweet t...smoothie aficionados seeking a taste of fame are i...
(Date:5/22/2008)...ntal drug has blocked the progression of prostate ...of the disease, new research shows. , The agent, ... histone deacetylase (HDAC) inhibitors, compounds ... against cancer but are turned off by the cancer p...University Comprehensive Cancer Center researchers...
(Date:5/22/2008)...rch Foundation recently awarded its top honors to ...at the 2008 Spring Research Review Awards Dinner. ...ence was established in 1974 by the actress Dina M...e highest honor JDRF awards, and is presented annu...d commitment to diabetes research and for their se...
(Date:5/22/2008)...swire-USNewswire/ -- Many baby boomers,incorrectly...ccording to a,new survey conducted by Harris Inter...Plans (AHIP). Most say that disability insurance i...lf say they do not have any disability,income prot...rnh/20040830/AHIPLOGO ), "Baby boomers recognize...
Breaking Medicine News(10 mins):Health News:Thirsting for Healthful Smoothie Recipes That 'got milk?' 2Health News:Experimental agent blocks prostate cancer in animal study 2Health News:JDRF announces 2008 Spring Research Review Award 2Health News:Many Baby Boomers Incorrectly Believe They Are Protected Against the Risk of Disability 2Health News:Many Baby Boomers Incorrectly Believe They Are Protected Against the Risk of Disability 3
... five more victims in Bataan, Rizal and Marikina C...alenzuela City and a four-and-a-half child from Ba...r. Ricardo Lustre, administrator of the Amang Rodr...ild was at “critical stage 4,” and died 10 hours a...
...atives to combat tropical diseases that ails many ...tin America//, was given a renewed thrust by The B...ur grants totaling to more than $68.2 million. Th...ee diseases - hookworm, leishmaniasis and trypanos...
... star Wayne Rooney, Coleen McLoughlin launched Chi...d her desire to raise awareness of the work hospic... funds.// Coleen, 20, has personal experience to s...Rosie, suffers from genetic disorder Rett Syndrome...
...iew that was published in the Friday’s issue of th...kids does not reduce their risk of fractures in th...f the maximum bone mass is got by the age of 18 ye...ng bone mass at an early age might reduce the effe...
Other Medicine News:
(Date:5/21/2008)...First Presentation of Full Data Set from the TRIUM... Treprostinil, SILVER SPRING, Md., May 21 /PRNews... (Nasdaq: UTHR ) and its wholly-owned subsidiary,... presentations concerning,the treatment of pulmona...ere reported at the American Thoracic Society (ATS...
(Date:5/21/2008)... Innovative pipeline products highlight Watson,s c...oed Until 2:10 PM EDT, ORLANDO, Fla., May 21 /PRN... (NYSE: WPI ), a leading specialty pharmaceutical...nted clinical data on two Phase 3 products at,the ...The abstracts include,a cardiac safety trial invol...
(Date:5/21/2008)... Tumor responses, safety and long-term survivors...h product approach, SAN FRANCISCO and YONGIN-SI, ... (San Francisco, CA and Ottawa, Ontario), and its ...today that Phase I clinical,trial results from its... in,the premier journal Lancet Oncology. The major...
(Date:5/21/2008)... Findings Show Cystic Fibrosis Patients Cough More... -, SOUTH PLAINFIELD, N.J., May 21 /PRNews...ced new data suggesting that the quantification of... outcome measure in cystic,fibrosis (CF). Cough is...related symptoms in CF. According to data presente...
Breaking Medicine Technology:Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 2Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 3Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 4Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 5Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 6Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 2Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 3Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 4Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 5Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 6Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 2Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 3Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 4PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 2PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 3PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 4YouTube Video to Benefit AIDS Babies 4653 1CNA Presents New Data on Sutters Medical Redlining 4650 1CNA Presents New Data on Sutters Medical Redlining 4650 2CNA Presents New Data on Sutters Medical Redlining 4650 3Sigma Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute 1515 1Sigma Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute 1515 2Sigma Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute 1515 3Hospital Romance May Largely Be Fiction 4649 1Hospital Romance May Largely Be Fiction 4649 2Hospital Romance May Largely Be Fiction 4649 3
...- Forest,Laboratories, Inc. and PAION AG today ann... In Acute Ischemic Stroke) study with the,compound...,investigate the improvement of clinical outcome i... Desmoteplase within 3 to 9 hours,after onset of s...,efficacy endpoint (difference between active trea...
... Research,collaborators with Oncolytics Biotech In...r presentation covering REOLYSIN(R),clinical trial...,(ASCO) Annual Meeting, to be held June 1-5, 2007 ...tics, U.K. Phase I systemic,administration trial. ... Study of,Wild-Type Oncolytic Reovirus Administere...
Other Medicine Technology:Topline Results of Phase III Study in Acute Ischemic Stroke,(Dias-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 2Topline Results of Phase III Study in Acute Ischemic Stroke,(Dias-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 3Topline Results of Phase III Study in Acute Ischemic Stroke,(Dias-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 4Oncolytics Biotech Inc.'s Research Collaborators to Present,REOLYSIN Clinical Trial Data at ASCO Conference 2
Lumitex® LightMat® Surgical Illuminator improves visualization in deep cavity surgery. Flexible and malleable, it attaches easily to most retractors, bringing bright, cool area lighting where
...HELION family consists of four models in proven ha...ure you find the right solution for every applicat... of two or three mobile lamps also battery-powered...h on the lamp housing, the standard-plus models of...
The Sunnex Celestial Star™ light is ideal for surgical applications. The flexible design allows for easy angling and positioning. The space-saving structure is ideal for many facilities includi
... new small incision surgical light is an industry ... for many surgeons. The DeepSite provides 10,000-f...hes, and can be positioned with one hand at distan...t is not tethered to the surgeon, so it allows tot...
Medicine Products: